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TRICYCLOQUINAZOLINE (TCQ; Fig. 1) has been shown to be carcinogenic for
mouse skin andto a lesser extentforrat subcutaneous tissue (Baldwin, Cunningham
and Partridge, 1959). Its activity as a skin carcinogen expressed as the Iball
index 44 (Iball, 1939) is intermediate between that of 1,2: 5,6-dibenzanthracene
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FIG. 1.-Tricycloquinazoline (TCQ).
(Iball index 25) and 3,4-benzopyrene (Iball index 75) (Badger, 1948). This
compound is unrelated to any homocyclic or heterocyclic hydrocarbon carcinogen
hitherto examined and thus represents a new class of chemical compound for the
investigation of the relationship between chemical structure and carcinogenic
activity. Studies have been initiated, therefore, with the aim of determining
the essential molecular criteria for carcinogenicity of TCQ and their implicit
relationships to the mechanism of carcinogenesis. For this purpose, systematic
modification is possible by substitution in the peripheral benzene rings, by altera-
tion in the arrangement and number of homocyclic and heterocyclic rings, in
the number, distribution, and nature of the heteroatoms, and by interference
with the planarity of the molecule.
The present report is concerned with the effect of substitution in the peripheral
benzene rings on carcinogenic activity following skin painting in mice. The four
possible monomethyl derivatives, together with 3,8-dimethyl TCQ and 3,8,13-
trimethyl TCQ have been examined. In addition derivatives containing halogen
or hydroxyl substituents have been assessed for carcinogenic activity for com-
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MATERLALS AND METHODS
Mice.-Stock albino mice (Schofield Strain) ofbothsexes and 6to 8 weeks oldat
the start of each experiment.
These were obtained commercially and maintained on a cubed diet (MRC diet
41) supplemented with fresh greenstuffs plus water ad libitum.
Skin painting.-Dorsal hair was removed from mice by clipping at the begin-
ning of each test and subsequently when necessary. Each compound was applied
dropwise to the skin from all-glass tuberculin syringes. Mice were treated twice
weekly with 0 3 ml. of solution for a period of up to 12 months. They were
examined for the presence of tumours at weekly intervals and were killed when
it was considered that tumours were malignant or when animals became ill. The
position of all tumours was then recorded and specimens ofskin, skin tumour and
other organs showing gross pathological change were taken for histological
examiniation.
Skin tumour incidences were assessed from the number of mice alive (at risk)
when tumours were first observed. The Iball Indices (Iball, 1939) were calculated
from the total tumour incidences.
Tricycloquinazoline derivatives
The syntheses and properties of the tricycloquinazoline derivatives have been
reported elsewhere (Partridge, Vipond, and Waite, 1962). Details of the com-
pounds and concentrations at which they were skin painted are shown in Table I.
All derivatives were skin painted in double re-distilled AR grade benzene. Solu-
tions were prepared at two weekly intervals and stored in glass stoppered bottles.
TABLE I.-Details of Tricycloquinazoline Derivatives
Concentration Total
tested dose
Compound (mg./ml.) (mg.)
Tricycloquinazoline (TCQ) . 1 24
I-Methyl-TCQ . . 1 . 31
2-Methyl-TCQ . . 1 . 31
3-Methyl-TCQ . . 1 . 31
4-Methyl-TCQ . 1 . 31
3-Fluoro-TCQ . 0 75 . 23
3-Bromo-TCQ . . 1 31
2-Methoxy-TCQ . . . 1 . 31
3,8-Dimethyl-TCQ . . 1 . 29
3,8,13-Trimethyl-TCQ . . 0 3 . 11
Benzene (controls) . - . 35 ml.
RESULTS
The Influence of methyl ring substitution on carcinogenic activity
The skin tumour incidences resulting from the application of tricycloquinazo-
line and monomethyl substituted derivatives to mouse skin are summarized in
Table II.
Significantly, one monomethyl derivative, 2-methyl-TCQ, was found to have
low carcinogenic activity. Thus skin tumours developed in only 5 mice (9 per
cent) and of these, only 2 (4 per cent) proved to be malignant. A similar skinCARCINOGENICITY OF TRICYCLOQUINAZOLINE
TABLE IT.-Skin Tumour Incidences in Mice Treated with Tricycloquinazoline
and Peripheral Ring Substituted Derivatives
Total Skin
Number Duration tumours Mean carcinomas
of mice ofexperi- , latent
at ment Per- period Iball Per-
Compound risk (days) Number centage (days) index Number centage
TCQ. . 36 471 . 29 81 . 186 . 44 . 27 75
I-Methyl-TCQ 20 570 11 55 . 316 . 17 . 9 45
2-Methyl-TCQ . 55 . 628 5 9 461 . 2 2 4
3-Methyl-TCQ . 44 516 26 59 296 20 . 21 48
4-Methyl-TCQ 18 548 . 8 44 . 282 16 8 44
3,8 -Dimethyl -TCQ 35 438 . 3 9 244 3 . 0 0
3,8,13 - Trimethyl - 54 456 . 9 17 277 . 6 . 5 9
TCQ
3-Fluoro-TCQ 17 . 551 13 76 . 375 . 20 . 11 61
3-Bromo-TCQ 22 503 15 68 274 . 25 . 15 68
2-Methoxy-TCQ. 33 546 . 4 12 . 321 . 4 . 2 6
Benzene (Solvent 58 . 518 4 7 . 345 2 . 4 7
control)
tumour incidence was observed in control studies following skin painting with
benzene (Table II) and thus this level of carcinogenic activity must be considered
of doubtful significance.
All other monomethyl derivatives showed carcinogenic activity although
somewhat less than that of the parent compound. Thus the total skin tumour
incidences following treatment with 1-, 3- and 4-monomethyl derivatives were
between 44 and 59 per cent whereas 81 per cent of mice at risk following skin
painting with TCQ developed skin tumours. Comparison of the incidences of
malignant skin tumours also reveals that the monomethyl derivatives are less
active than the parent compound. With TCQ, malignant skin tumours were
observed in 75 per cent of mice at risk whereas the incidences in 1-, 3- and 4-
monomethyl TCQ-treated mice were between 44 and 48 per cent.
The differences in carcinogenic activity between TCQ and monomethyl
derivatives are even more striking when the latent periods for tumour induction
are taken into consideration. With TCQ, 50 per cent ofmice at risk had developed
tumours after 7 months of treatment and by 8 months, the tumour incidence was
78 per cent. Between completion of skin painting (280 days) and termination of
the experiment (471 days), only one further mouse developed skin tumours and
thus practically all the tumours arose during the skin painting period. This is
illustrated in Fig. 2 which shows the total skin tumour incidences recorded at
monthly intervals during the testing of TCQ and monomethyl derivatives.
Skin tumours developed much more slowly in mice treated with 1-, 3- and 4-
methyl derivatives. Thus following 8 months' treatment with these compounds,
skin tumours were observed in only 14 to 16 per cent of mice and by completion
of skin painting (12 months) tumour incidences were still low (33 to 39 per cent,
Fig. 2). Further tumours arose during the 6 months, observation period following
completion of skin painting and when these studies were terminated (18 months)
the final tumour incidences were between 44 and 59 per cent.
In order to assess the influence ofmultiple ring methyl substitution the carcino-
genicity of 3,8,13-trimethyl-TCQ was examined. This compound proved to be
weakly active, skin tumours developing in 5 mice (9 per cent) during the period
of skin painting and when the experiment was terminated after 18 months, the
final tumour incidence was 17 per cent (carcinoma incidence 9 per cent, Table II).
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Comparison of the potency of this compound with other TCQ derivatives is
complicated because ofits limited solubility (0 3 mg./ml. in benzene) and therefore
the more soluble 3,8-dimethyl-TCQ derivative was also examined. Although
Months
FIG. 2.-Development of skin tumours in mice treated with
TCQ and methyl-substituted derivatives.
O O TCQ.
* * 2-Methyl-TCQ.
A A 4-Methyl-TCQ.
* * I-Methyl-TCQ.
x x 3-Methyl-TCQ.
G 0- 3,8,13-trimethyl-TCQ.
studies with this compound are not fully completed, the results indicate that it
possesses only very weak carcinogenic activity (Table II). Thus during the period
of skin painting tumours developed in 3 mice (9 per cent) but these regressed.
Skin tumours arose in a further two mice after the completion of skin painting
and at present (14 months) these are the only detectable tumours.
The influence ofhalogen and hydroxyl substitution
In order to assess the influence of peripheral ring blocking with substituents
other than the methyl group, the halogen derivatives, 3-fluoro-TCQ and 3-bromo-
TCQ were examined. The skin tumour incidence in mice treated with 3-fluoro-
TCQ was 76 per cent (carcinoma incidence 61 per cent) which is comparable to
that obtained with TCQ (Table II). However, as shown in Fig. 3, compared with
TCQ, tumours developed much later in 3-fluoro-TCQ treated mice, the pattern of
tumour induction being more comparable to that observed with 3-methyl-TCQ.
3-Bromo-TCQ also proved to be carcinogenic, skin tumours developing in
68 per cent ofmice at risk (carcinoma incidence 68 per cent). The carcinogenicity
of this compound is comparable to that of 3-fluoro-TCQ although, as shown inCARCINOGENICITY OF TRICYCLOQUINAZOLINE
Fig. 3, the latent period for tumour induction was less than that observed with
either 3-fluoro- or 3-methyl-TCQ. Thus 50 per cent of mice at risk following
treatment with 3-bromo-TCQ had developed skin tumours after 10 months,
whereas with 3-fluoro- and 3-methyl-TCQ, 50 per cent tumour incidences were
not observed until between 13 to 14 months.
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FIG. 3.-Development of skin tumours in mice treated with
halogen- and methoxyl-substituted derivatives.
O O TCQ. * * 3-Bromo-TCQ.
A A 3-Fluoro-TCQ [ -O 2-Methoxy-TCQ.
In view ofthe importance ofthe observation oflow carcinogenic activity with
2-methyl-TCQ, the carcinogenicity of 2-methoxy-TCQ was determined to further
assess the effect of substitution in the 2- position. This compound also proved to
be weakly carcinogenic; skin tumours developing in only 4 mice (12 per cent),
and ofthese only 2 proved to be malignant (Table II).
Histologicalfindings
The majority of skin tumours in mice treated with TCQ or peripheral ring
substituted derivatives arose within the area of skin subjected to treatment.
Additionally, a number of tumours arose on unpainted areas particularly around
the head and shoulders, presumably due to the animals licking the compounds.
Histological examination of skin tumours indicated that the majority of
malignant tumours were squamous cell carcinomata. In addition, there were also
a number of basal cell carcinomas and an occasional sweat gland adenoma.
279280 R. W. BALDWIN, G. J. CUNNINGHAM, M. W. PARTRIDGE AND H. J. VIPOND
DISCUSSION
The most important finding resulting from the investigation of carcinogenic
activity in derivatives of tricycloquinazoline (Fig. 1) containing methyl substi-
tuents in the peripheral benzene rings is that 2-methyl-TCQ is virtually inactive
whereas the other three possible monomethyl derivatives namely, 1-, 3- or 4-
methyl-TCQ have comparable carcinogenic activities although somewhat less
than that of the parent compound. That substitution in the 2-position produces
complete or almost complete loss of carcinogenicity is further supported by the
finding of low activity in 2-methoxy-TCQ (Table II); studies still incomplete
with 2-hydroxy-TCQ (12 months) have failed to show any carcinogenic activity
in this compound.
These findings suggest that the 2- position is involved in TCQ carcinogenesis.
Since however, there are two other ring positions (7 and 12, see Fig. 1) which are
equivalent to the 2-position in the TCQ molecule, it would be expected that block-
ing of only one position would reduce but not abolish carcinogenic activity. The
reasons for this loss of carcinogenicity following methylation at the 2-position
cannot yet be explained but one possible interpretation is that the primary action
ofthe carcinogen at the tissue receptor involves at least a three-point union which
is sterically influenced by substituents at the 2, 7 or 12 positions.
The mode of metabolism of tricycloquinazoline is still undetermined, but by
virtue of the symmetry of the molecule, metabolic attack would be expected to
occur at any of three sets of equivalent positions in the molecule, either in the
peripheral benzenerings or at aC-N bond within the central nucleus. Substitution
atthe 2- position would not beexpected to affect the metabolism oftricycloquinazo-
line and it has been shown (Baldwin, Palmer and Partridge, 1961) that the rates
ofmetabolic breakdown of2-methyl-TCQ and3-methyl-TCQ areessentially similar.
The finding that monomethyl substitution at the 2- position almost completely
abolishes carcinogenic activity further indicates therefore that the whole TCQ
molecule rather than a metabolite is the proximate carcinogen.
Derivatives containing methyl substituents at the 1-, 3-, or 4- positions are
all carcinogenic although compared to the parent compound, activity is reduced.
Introduction of additional methyl substituents causes a further decrease in
carcinogenicity and thus 3, 8-dimethyl-TCQ and 3,8,13-trimethyl-TCQ are only
weakly active (Table II). This gradual decrease in carcinogenic activity with
the introduction of methyl substituents into the 3- or equivalent positions in the
peripheral benzene rings (Fig. 1), it is suggested, may be due to an increasing
interference with a carcinogen-receptor union.
The effects of methyl substitution on the carcinogenicity of tricycloquinazoline
differ markedly from the findings with other epidermal hydrocarbon carcinogens
(Badger, 1948, 1954). Thus in the 1,2-benzanthracene series, methyl substitution
at any position in the anthracene residue generally enhances activity. Dimethyl-
benzanthracenes are also more potent than either of the monomethyl derivatives
to which they are related. Monomethyl substitution in the angular benzene
ring does not however enhance carcinogenicity and dimethyl derivatives in
which one methyl substituent is in the angular ring are also inactive. The
enhancement of carcinogenicity by methyl substitution in the 9- and 10- positions
in benzanthracene has been interpreted in terms of electron densities at the K and
L regions (Pullman and Pullman, 1955) although loss of activity by substitutionCARCINOGENICITY OF TRICYCLOQUINAZOLINE
in the angular ring has not been explained other than to suggest some possible
stereochemical influence (Badger, 1954).
Enhancement of carcinogenic activity following methyl substitution has also
been observed in the benzophenanthrene series. Comparison ofthe carcinogenici-
ties of methylbenzopyrenes following subcutaneous injection has revealed that
all excepting the 2'- and 3'- derivatives were active. Only one of these com-
pounds (3'-methylbenzopyrene) has been examined following skin painting and
in this case the compound was inactive (Schurch and Winterstein, 1935).
The most comprehensive investigation in recent years of the relationship of
chemical structure to carcinogenic activity is that of Lacassagne et al. (1956) with
the angular benzacridines and dibenzacridines. In these studies it was also shown
that carcinogenicity was enhanced by methyl substitution; the most important
finding being that carcinogenic members were substituted in the meso-anthracenic
carbon. Correlations with the electron densities of the K and L regions in these
series of compounds have been employed in theoretical interpretations of their
activities.
Hypotheses relating carcinogenic activity to electron densities of K and L
regions appear to be irrelevant to TCQ since this compound contains no region
identifiable as a K region. The evidence relating structure to activity in TCQ and
its derivatives can be most logically accommodated in terms of the precision of
stereochemical fit of the planar carcinogen by multiple bonding to a planar
receptor site.
The almost complete suppression of activity by 2-methylation, 2-methoxyla-
tion, or 2-hydroxylation could be interpreted as evidence for the union of TCQ to
a receptor at the 2-, 7- and 12- positions of the peripheral benzene rings. How-
ever a union specifically limited to these three positions would appear to require
co-valent bonding of the carcinogen to the receptor, analogously to the co-valent
binding of 1,2: 5,6-dibenzanthracene to protein (Heidelberger, 1959). No evi-
dence of such binding has been obtained (Baldwin, Palmer and Partridge, 1960)
since TCQ can be removed from skin by simple washing with solvents; evidently
the carcinogen-receptor union involves weak intermolecular attractions.
Possible weak attractions are hydrogen bonding to the three peripheral nitro-
gen atoms, overlap of 7T-orbitals of the carcinogen and the tissue receptor, or
multiple van der Waals bonding of a coplanar carcinogen and receptor. The
amidine arrangement ofthe nitrogen atoms both in TCQ and in the planar bonded
purine and pyrimidine pairs in DNA may be relevant to the possibility of the
hydrogen bonding. Loss of activity induced by 2- substitution is readily en-
visaged as arising from a blocking of multiple weak bonding by steric hindrance
TABLE III.-Correlation of the Skin Tumour Incidences of 3- or Equivalent
Substituted TCQ Derivatives with the van der Waals radii of the Substituents
van der Waals
radius of Tumour
substituent incidence
Substituent (X) (percentage)
3-H . . 1-2 . 81
3-Fluoro. 1-35 . 76
3-Bromo . . 1-95 . 68
3-Methyl . 2-0 59
3,8-Dimethyl . . 2 x 2 - 0 8
3,8,13-Trimethyl 3 x2 17
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between the substituent and any of three appropriately positioned functional
groups adjacent to the receptor. Partial loss of activity caused by substituents
in other positions in the peripheral homocyclic rings in TCQ could then be related
to lower degrees of steric hindrance of the formation of a carcinogen-receptor
union.
Evidence in harmony with the suggestion that stereochemical fit controls
carcinogenic activity is implicit in the correlation between the incidence oftumours
and the van der Waals radii of substituents of the 3- or equivalent 8- and 13-
positions (Table III).
SUMMARY
1.-Tricycloquinazoline (TCQ), a polyazapolycyclic hydrocarbon, is unrelated
to any other epidermal hydrocarbon carcinogen and thus represents a new class of
chemical compound for the investigation of the relationship between chemical
structure and carcinogenicity.
2.-One ofthefour possiblemonomethyl derivatives, 2-methyl-TCQ, was virtual-
lyinactive following skinpaintingonmice, suggesting thatthe 2- positionisinvolved
in TCQ carcinogenesis. This is further supported by the finding of very low
activity with 2-methoxy-TCQ.
- 3.-The three other possible monomethyl derivatives, 1-, 3- and 4-methyl-TCQ
were all carcinogenic although their activities were less than that of the parent
compound. Introduction of additional methyl substituents in positions equiva-
lent to the 3- position caused further significant decreases in carcinogenic activity,
and 3,8-dimethyl-TCQ and 3,8,13-trimethyl-TCQ were only weakly carcinogenic.
4.-The implications ofthese findings toTCQ carcinogenesis are discussed. The
evidence relating structure to activity in TCQ and its derivatives can best be
interpreted in terms of a stereochemical fit of the planar carcinogen by multiple
bonding to a planar tissue receptor site. Unlike other polycyclic hydrocarbons,
TCQ is not strongly bound to epidermal structures and thus the carcinogen-
receptor union must involve weak intermolecular attractions.
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